13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
FILER PROFILE · CIK 0001694560

New Enterprise Associates 16, L.P.

10 filings 6 distinct issuers Active 2019-02-22 → 2025-08-18

Track Record

Total filings
10
2 SCHEDULE · 8 SC
Distinct issuers
6
60% issuer diversity
Median stake
12.3%
8,349,879 avg shares
AI briefs cached
0/10
intent-classified filings

Backtested Performance · post-filing returns (split + dividend adjusted)

Median 30d
0.0%
across 2 filings · win rate 0%
Median 60d
0.0%
across 2 filings · win rate 0%
Median 90d
0.0%
across 2 filings · win rate 0%
Median 1y
—
across 0 filings · win rate —

Anchor: closest trading day on/after filing's date_of_event. Source: Yahoo Finance daily adj_close. Past performance is not indicative of future results.

Filings · 10 total

FiledFormIssuerStakeSharesIntent
2025-08-18 SCHEDULE Marker Therapeutics, Inc.MRKR 12.60% 1,625,678 view →
2025-08-11 SCHEDULE Trevi Therapeutics, Inc.TRVI 12.00% 15,074,080 view →
2022-01-05 SC Metacrine, Inc. — — view →
2021-04-14 SC GENOCEA BIOSCIENCES, INC. — — view →
2021-03-26 SC Marker Therapeutics, Inc.MRKR — — view →
2021-03-11 SC Allakos Inc. — — view →
2020-08-03 SC GENOCEA BIOSCIENCES, INC. — — view →
2020-04-16 SC Trevi Therapeutics, Inc.TRVI — — view →
2019-05-28 SC X4 Pharmaceuticals, IncXFOR — — view →
2019-02-22 SC GENOCEA BIOSCIENCES, INC. — — view →

Alert me when New Enterprise Associates 16, L.P. files anything

Free. We email you when criteria match. One-click unsubscribe in every email.

Track this filer's every move in real time.

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →